Does anyone have an opinion on or experience with Mayne's track record on reliability of their forward looking statements? If they say generic sales will improve, should we take it at face value and rely on it?
- Forums
- ASX - By Stock
- MYX
- News: MYX Mayne Pharma Expects Q4 To Be Stronger Driven By Rebound In Generic Products
News: MYX Mayne Pharma Expects Q4 To Be Stronger Driven By Rebound In Generic Products, page-2
-
- There are more pages in this discussion • 64 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MYX (ASX) to my watchlist
|
|||||
Last
$4.65 |
Change
-0.130(2.72%) |
Mkt cap ! $395.5M |
Open | High | Low | Value | Volume |
$4.72 | $4.76 | $4.56 | $825.4K | 176.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 1960 | $4.62 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$4.68 | 123 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 1960 | 4.620 |
2 | 1210 | 4.610 |
3 | 7160 | 4.600 |
2 | 2960 | 4.590 |
1 | 960 | 4.580 |
Price($) | Vol. | No. |
---|---|---|
4.680 | 123 | 1 |
4.690 | 123 | 1 |
4.700 | 123 | 1 |
4.710 | 123 | 1 |
4.720 | 1083 | 2 |
Last trade - 16.10pm 04/09/2024 (20 minute delay) ? |
Featured News
MYX (ASX) Chart |